Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
67.90    1.90 (2.88%)
Bid:
66.10
Ask:
67.90
Spread: 1.80 (2.723%)
Market Cap: £105.61m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Trading Update

28 Nov 2024 07:00

RNS Number : 9131N
Macfarlane Group PLC
28 November 2024
 

28 November 2024

MACFARLANE GROUP PLC

("MACFARLANE GROUP", "THE GROUP")

Trading Update

Effective response to market headwinds

Macfarlane Group PLC, the protective packaging specialist, today provides an update on trading for the period 1 January to 31 October 2024.

· The Board anticipates the Group's performance for 2024 will be broadly in line with its full year expectations.

· Revenue year to date is 4% below the same period last year, with continued challenging market conditions resulting in weaker volumes and lower pricing impacting most sectors.

· These impacts are being offset by improved new business performance, effective management of pricing and costs and the completion of two acquisitions during the period, both of which are performing well.

· The Group continues to progress its strong acquisitions pipeline.

· A strong balance sheet and cash generation, supported by a £35m bank facility, underpin the Group's strategy; net bank debt at 31 October 2024 was £4.7m (30 June 2024: Net bank funds of £0.8m), after £11.3m of investment in acquisitions and payment of dividends of £5.8m.

· The increase in employers' national insurance rates and National Minimum Wage announced in the UK Government Budget on 30 October 2024 will increase the Group's costs by c£1.5m annually from April 2025. Mitigation actions are currently being reviewed to minimise the impact.

Aleen Gulvanessian, Chair of Macfarlane Group, said:

"As outlined in our Interim Results, the management team is responding effectively to the market headwinds. Our strong balance sheet gives us confidence we can continue to execute accretive acquisitions. There is good new business momentum as customers increasingly recognise the added value we can offer both on an environmental and cost savings basis. The Group remains well-positioned to benefit when the macro-economic outlook improves."

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Aleen Gulvanessian Chair

Peter Atkinson Chief Executive

Ivor Gray Finance Director

Spreng Thomson

Callum Spreng

Mob: 07803 970103

 

Legal Entity Identifier (LEI): 213800LVRYDERSJAAZ73

Notes to Editors:

· Macfarlane Group PLC has been listed on the Main Market of the London Stock Exchange plc (LSE: MACF) since 1973 with over 70 years' experience in the UK packaging industry.

· Through its two divisions, Macfarlane Group services a broad range of business customers, supplying them with high quality protective packaging products which help customers reduce supply chain costs, improve operational efficiencies and sustainability and enhance their brand presentation. The divisions are:

o Packaging Distribution - Macfarlane Packaging Distribution is the leading UK distributor of a comprehensive range of protective packaging products; and

o Manufacturing Operations - Macfarlane Design and Manufacture is a UK market leader in the design and production of protective packaging for high value and fragile products.

· Headquartered in Glasgow, Scotland, Macfarlane Group employs over 1,000 people at 40 sites, principally in the UK, as well as in Ireland, Germany and the Netherlands.

· Macfarlane Group supplies more than 20,000 customers, principally in the UK and Europe.

· In partnership with 1,700 suppliers, Macfarlane Group distributes and manufactures 600,000+ lines supplying to a wide range of sectors, including: retail e-commerce; consumer goods; food; logistics; mail order; electronics; defence; medical; automotive; and aerospace.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRLSLDFIS
Date   Source Headline
23rd Nov 20237:00 amRNSTrading Update
31st Oct 20238:19 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSAcquisition of B&D 2010 Group Limited
29th Aug 20237:00 amRNSIssue of Shares
24th Aug 20237:00 amRNSHalf-year Report
8th Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
4th Aug 20237:00 amRNSNotice of Results
6th Jul 20231:29 pmRNSHolding(s) in Company
9th May 20233:08 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 20237:00 amRNSAcquisition
28th Apr 20235:17 pmRNSNotice of AGM
20th Apr 20235:18 pmRNSHolding(s) in Company
20th Apr 20232:03 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSAnnual Report 2022
27th Mar 202312:29 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSAcquisition
23rd Feb 20237:00 amRNSAnnual Results 2022
15th Feb 20237:00 amRNSNotice of Results
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Nov 20227:00 amRNSDirector/PDMR Shareholding
24th Nov 20227:00 amRNSTrading Update
7th Oct 202210:00 amRNSHolding(s) in Company
7th Oct 202210:00 amRNSHolding(s) in Company
27th Sep 20221:57 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSAppointment of Non-Executive Director
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
25th Aug 20227:16 amRNSHalf-year Report
5th Aug 20227:00 amRNSNotice of Results
19th May 20227:00 amRNSDirector/PDMR Shareholding
17th May 202212:00 pmRNSAcquisition
16th May 20227:00 amRNSIssue of Shares
10th May 20223:24 pmRNSResult of AGM
10th May 202212:00 pmRNSTrading Update
6th Apr 20227:00 amRNSNotice of AGM
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Report 2021
25th Mar 20224:12 pmRNSDirector/PDMR Shareholding
11th Mar 20223:41 pmRNSDirector/PDMR Shareholding
24th Feb 20221:00 pmRNSDividend Payment Date
24th Feb 20227:00 amRNSFinal Results
11th Feb 20227:00 amRNSNotice of Results
4th Jan 20227:00 amRNSDisposal
25th Nov 20217:00 amRNSTrading Update
18th Nov 202110:17 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
6th Aug 20217:00 amRNSNotice of Interim Results
25th Jun 20214:41 pmRNSSecond Price Monitoring Extn
25th Jun 20214:36 pmRNSPrice Monitoring Extension
12th May 20217:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.